Literature DB >> 30993588

A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.

Yen-Bin Hsu1,2, Ming-Chin Lan3,4, Yu-Lun Kuo5, Chi-Ying F Huang6,7, Ming-Ying Lan8,9.   

Abstract

Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism. Methods The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells. Results Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling. Conclusion Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future.

Entities:  

Keywords:  Anticancer drug; Microarray; Nasopharyngeal carcinoma; Thiostrepton

Mesh:

Substances:

Year:  2019        PMID: 30993588     DOI: 10.1007/s10637-019-00779-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  55 in total

1.  The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A.

Authors:  G Rosendahl; S Douthwaite
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

2.  Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer.

Authors:  Gina L Westhoff; Yi Chen; Nelson N H Teng
Journal:  Int J Gynecol Cancer       Date:  2017-06       Impact factor: 3.437

3.  Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.

Authors:  Lizhu Jiang; Peng Wang; Lili Chen; Hongyan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.

Authors:  Mingguang Liu; Bingbing Dai; Shin-Hyuk Kang; Kechen Ban; Feng-Ju Huang; Frederick F Lang; Kenneth D Aldape; Tong-xin Xie; Christopher E Pelloski; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

5.  The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Authors:  Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

6.  TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

Authors:  Joseph C Loftus; Harshil Dhruv; Serdar Tuncali; Jean Kloss; Zhongbo Yang; Cassie A Schumacher; Brian Cao; Bart O Williams; Jennifer M Eschbacher; Julianna T D Ross; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2013-05-22       Impact factor: 5.852

7.  Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates.

Authors:  Cristinel Sandu; Nagaranjan Chandramouli; Joseph Fraser Glickman; Henrik Molina; Chueh-Ling Kuo; Nikolay Kukushkin; Alfred L Goldberg; Hermann Steller
Journal:  J Cell Mol Med       Date:  2015-05-30       Impact factor: 5.310

8.  AAM-B Interacts with Nonstructural 4B and Regulates Hepatitis C Virus Propagation.

Authors:  Eun-Mee Park; Yun-Sook Lim; Byung-Yoon Ahn; Soon B Hwang
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

9.  Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.

Authors:  S-Y Ju; C-Y F Huang; W-C Huang; Y Su
Journal:  Cell Death Dis       Date:  2015-07-02       Impact factor: 8.469

10.  FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Authors:  Emilios Gemenetzidis; Amrita Bose; Adeel M Riaz; Tracy Chaplin; Bryan D Young; Muhammad Ali; David Sugden; Johanna K Thurlow; Sok-Ching Cheong; Soo-Hwang Teo; Hong Wan; Ahmad Waseem; Eric K Parkinson; Farida Fortune; Muy-Teck Teh
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more
  1 in total

1.  Podoplanin, a Potential Therapeutic Target for Nasopharyngeal Carcinoma.

Authors:  Yen-Bin Hsu; Chi-Ying F Huang; Kuan-Ting Lin; Yu-Lun Kuo; Ming-Chin Lan; Ming-Ying Lan
Journal:  Biomed Res Int       Date:  2019-06-20       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.